|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mayer RJ, Venook AP and Schilsky RL:
Progress against GI cancer during the American Society of Clinical
Oncology's first 50 years. J Clin Oncol. 32:1521–1530. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Venook AP, Weiser MR and Tepper JE:
Colorectal cancer: All hands on deck. Am Soc Clin Oncol Educ Book.
34:83–89. 2014. View Article : Google Scholar
|
|
5
|
Watanabe T, Itabashi M, Shimada Y, Tanaka
S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, et
al: Japanese Society for Cancer of the Colon and Rectum: Japanese
Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014
for treatment of colorectal cancer. Int J Clin Oncol. 20:207–239.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: Emt: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bae KM, Parker NN, Dai Y, Vieweg J and
Siemann DW: E-cadherin plasticity in prostate cancer stem cell
invasion. Am J Cancer Res. 1:71–84. 2011.PubMed/NCBI
|
|
10
|
Nakagawa H, Inazawa J, Inoue K, Misawa S,
Kashima K, Adachi H, Nakazato H and Abe T: Assignment of the human
renal dipeptidase gene (DPEP1) to band q24 of chromosome 16.
Cytogenet Cell Genet. 59:258–260. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jeong CH, Bode AM, Pugliese A, Cho YY, Kim
HG, Shim JH, Jeon YJ, Li H, Jiang H and Dong Z: [6]-Gingerol
suppresses colon cancer growth by targeting leukotriene A4
hydrolase. Cancer Res. 69:5584–5591. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bellamkonda K, Chandrashekar NK, Osman J,
Selvanesan BC, Savari S and Sjölander A: The eicosanoids
leukotriene D4 and prostaglandin E2 promote the tumorigenicity of
colon cancer-initiating cells in a xenograft mouse model. BMC
Cancer. 16:4252016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Austruy E, Cohen-Salmon M, Antignac C,
Béroud C, Henry I, Nguyen VC, Brugières L, Junien C and Jeanpierre
C: Isolation of kidney complementary DNAs down-expressed in Wilms'
tumor by a subtractive hybridization approach. Cancer Res.
53:2888–2894. 1993.PubMed/NCBI
|
|
14
|
Zhang G, Schetter A, He P, Funamizu N,
Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, et al:
DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity
and predicts clinical outcome in pancreatic ductal adenocarcinoma.
PLoS One. 7:e315072012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Green AR, Krivinskas S, Young P, Rakha EA,
Paish EC, Powe DG and Ellis IO: Loss of expression of chromosome
16q genes DPEP1 and CTCF in lobular carcinoma in situ of the
breast. Breast Cancer Res Treat. 113:59–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eisenach PA, Soeth E, Röder C, Klöppel G,
Tepel J, Kalthoff H and Sipos B: Dipeptidase 1 (DPEP1) is a marker
for the transition from low-grade to high-grade intraepithelial
neoplasia and an adverse prognostic factor in colorectal cancer. Br
J Cancer. 109:694–703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park SY, Lee SJ, Cho HJ, Kim TW, Kim JT,
Kim JW, Lee CH, Kim BY, Yeom YI, Lim JS, et al: Dehydropeptidase 1
promotes metastasis through regulation of E-cadherin expression in
colon cancer. Oncotarget. 7:9501–9512. 2016.PubMed/NCBI
|
|
18
|
Sobin LH and Compton CC: TNM seventh
edition: what's new, what's changed: communication from the
International Union Against Cancer and the American Joint Committee
on Cancer. Cancer. 116:5336–5339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
International Union Against Cancer (UICC),
. TNM Classification of Malignant Tumors. Sobin LH, Gospodarowicz
MK and Wittekind C: 7th edition. Wiley-Blackwell; Oxford, UK:
2009
|
|
20
|
Okabe N, Ezaki J, Yamaura T, Muto S, Osugi
J, Tamura H, Imai J, Ito E, Yanagisawa Y, Honma R, et al: FAM83B is
a novel biomarker for diagnosis and prognosis of lung squamous cell
carcinoma. Int J Oncol. 46:999–1006. 2015.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shao DD, Xue W, Krall EB, Bhutkar A,
Piccioni F, Wang X, Schinzel AC, Sood S, Rosenbluh J, Kim JW, et
al: KRAS and YAP1 converge to regulate EMT and tumor survival.
Cell. 158:171–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Chen YL, Ji G, Fang W, Gao Z, Liu
Y, Wang J, Ding X and Gao F: Sorafenib inhibits
epithelial-mesenchymal transition through an epigenetic-based
mechanism in human lung epithelial cells. PLoS One. 8:e649542013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Imielinski M, Greulich H, Kaplan B, Araujo
L, Amann J, Horn L, Schiller J, Villalona-Calero MA, Meyerson M and
Carbone DP: Oncogenic and sorafenib-sensitive ARAF mutations in
lung adenocarcinoma. J Clin Invest. 124:1582–1586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu R, Li J, Xie K, Zhang T, Lei Y, Chen
Y, Zhang L, Huang K, Wang K, Wu H, et al: FGFR4 promotes
stroma-induced epithelial-to-mesenchymal transition in colorectal
cancer. Cancer Res. 73:5926–5935. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hagel M, Miduturu C, Sheets M, Rubin N,
Weng W, Stransky N, Bifulco N, Kim JL, Hodous B, Brooijmans N, et
al: First Selective Small Molecule Inhibitor of FGFR4 for the
Treatment of Hepatocellular Carcinomas with an Activated FGFR4
Signaling Pathway. Cancer Discov. 5:424–437. 2015. View Article : Google Scholar : PubMed/NCBI
|
